25/05/2026
QCR’s Ecosystem – Enabling Efficient Single Ethics Review for Multicentric Studies
As part of ongoing regulatory reforms to accelerate clinical research approvals in India, the Indian Council of Medical Research (ICMR) has released operational guidance on the Single Ethics Committee (EC) Review mechanism for multicentric studies on International Clinical Trials Day.
This guidance is a significant step toward:
✔️ Reducing approval timelines
✔️ Minimizing duplication in submissions
✔️ Streamlining protocol amendment reviews across participating sites
The framework emphasizes:
🔹 Harmonized EC review processes
🔹 Digitized submission & communication systems
🔹 Coordinated review mechanisms between Central ECs and local ECs
🔹 Improved transparency, compliance & oversight
🚀 Future-Ready Digital Support from QCR With future-ready digital capabilities, QCR’s eIRB ecosystem and experienced Ethics Committee support team are well-positioned to support institutions, sponsors, CROs, and investigators in adopting this evolving regulatory model effectively.
The QCR eIRB platform — already supporting multiple multicentric studies and having processed 13,000+ research applications — enables:
✅ Single-Window Submission
Submit one harmonized protocol along with all site-specific documents through a unified digital platform, minimizing duplication and administrative burden.
✅ Centralized Coordination
Facilitates seamless communication between the Coordinating PI (c-PI), participating sites, and reviewing ECs for synchronized study ex*****on.
✅ Accelerated Review Timelines
Automated workflows, structured review pathways, and real-time query management help enable faster ethics review and approvals.
✅ Complete Lifecycle Tracking
Track submissions, approvals, amendments, continuing review activities, and decisions with full transparency and audit-ready documentation.
✅ Enhanced Compliance & Participant Safety
Integrated modules for:
• SAE reporting
• Protocol deviations
• CAPA management
• Continuing review
…help strengthen oversight and participant protection.
💡 Outcome
✔️ Reduced timelines
✔️ Improved regulatory compliance
✔️ Enhanced transparenc